EUVIMEDEUVIMED entdecken
Crossref

Viability of selected microorganisms in parenteral preparations for novel systemic anti-cancer therapy

Jannik Almasi iD, Laura Knoll, Judith Thiesen, Irene Krämer iD

Journal of Oncology Pharmacy Practice · 2024

DOI: 10.1177/10781552231179185 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Oncology Pharmacy Practice, 2024. Verfasst von Jannik Almasi und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacy, University Medical Center, Johannes Gutenberg-University, Mainz, Germany. Hauptthemen laut MEDLINE: Candida albicans, Pseudomonas aeruginosa, Antineoplastic Agents. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 26 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Risk factors for aseptic preparation of parenteral medicines encompass the growth-promoting nature of the preparation. Although many aqueous parenteral preparations do not have growth-promoting properties, inadvertently introduced microorganisms may remain viable. Knowledge about the viability of microorganisms in parenteral preparations can add useful information for assigning shelf life to preparations used to treat cancer patients.

Aim

The aim of the study was to assess the viability of four different facultative pathogenic microorganisms in 20 ready-to-administer parenteral preparations aseptically prepared in hospital pharmacies.

Methods

Samples of 20 different biologics and small molecules for systemic anti-cancer therapy were inoculated either with different bacteria (i.e., Staphylococcus aureus, Pseudomonas aeruginosa, Enterococcus faecium) or with Candida albicans suspension. The resulting test concentrations were 10 4 –10 5 microorganisms per mL. Aliquots of inoculated test solutions were transferred in duplicate to tryptic soy agar plates at the time points 0, 4, 24, 48, 144 h. The plates were incubated for 24 h (bacterial strains) and 72 h ( C. albicans) at 37 °C and colony forming units (CFUs) were counted.

Results

In most test solutions, especially in monoclonal antibody solutions, increased CFU counts of P. aeruginosa and unchanged or increased CFU counts of E. faecium and S. aureus were registered . Pronounced nutritive properties of monoclonal antibodies and filgrastim were not registered. Azacitidine, pixantrone and vinflunine containing test solutions revealed species-specific bacteriostatic and even bactericidal activity. All test solutions, except nivolumab and pixantrone containing solutions, showed constant or increasing CFU counts of C. albicans after incubation.

Conclusion

Viability of the selected pathogenic microorganisms was retained in most of the tested biological and small molecule preparations used to treat cancer patients. Therefore, in pharmacy departments strict aseptic conditions should be regarded and the lack of antimicrobial activity should be considered when assigning shelf life to RTA parenteral preparations.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Candida albicansPseudomonas aeruginosaAntineoplastic AgentsHumansStaphylococcus aureusMicrobial ViabilityEnterococcus faeciumInfusions, ParenteralDrug ContaminationPharmacy Service, HospitalColony Count, MicrobialBiological ProductsDrug Compounding

Stichwörter der Autor:innen

Viabilityantimicrobial activityparenteral preparationssystemic anti-cancer therapy

Substanzen

Antineoplastic AgentsBiological Products

Autor:innen und Institutionen

  • Department of Pharmacy, University Medical Center, Johannes Gutenberg-University, Mainz, Germany.

ORCID-Profile: Jannik Almasi, Irene Krämer

Zitieren

APA

Almasi, J., Knoll, L., Thiesen, J., & Krämer, I. (2024). Viability of selected microorganisms in parenteral preparations for novel systemic anti-cancer therapy. Journal of Oncology Pharmacy Practice. https://doi.org/10.1177/10781552231179185

Vancouver

Almasi J, Knoll L, Thiesen J, Krämer I. Viability of selected microorganisms in parenteral preparations for novel systemic anti-cancer therapy. Journal of Oncology Pharmacy Practice. 2024. doi:10.1177/10781552231179185

BibTeX
@article{Almasi2024,
  author = {Almasi, Jannik and Knoll, Laura and Thiesen, Judith and Krämer, Irene},
  title = {Viability of selected microorganisms in parenteral preparations for novel systemic anti-cancer therapy},
  journal = {Journal of Oncology Pharmacy Practice},
  year = {2024},
  doi = {10.1177/10781552231179185}
}
Kostenlos starten →